We’re glad to have gone along for the MTXX ride and were rewarded again today on news.
WASHINGTON, July 2 (Reuters) – Shares of Matrixx Initiatives (MTXX) soared as much as 30 percent on Thursday after the U.S. Food and Drug Administration released its official inspection report….The report noted that after the May 26-29 inspection, Matrixx’s vice president for research, development and product quality, told the inspector that the company had ‘nearly completed an extensive revision’ of its complaint procedures. Link to full text,
FDA releases Zicam report, Matrixx stock rise - Forbes.com.
Quote:
Originally Posted by The Market Order
Wrote this on June 17th:
After taking a 70% hit yesterday after the FDA asked for a recall of their homeopathic cold remedy Zicam, MTXX bounces as we predicted yesterday. The stock opened at $5.64 cents where we called it and then came just shy of seven bucks in trading today as panic subsided and shorts bought back to close their positions.
Matrixx Bounces As Predicted The Market Order |
Checking For Related Data...
